These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31756346)

  • 1. Neural circuits linking sleep and addiction: Animal models to understand why select individuals are more vulnerable to substance use disorders after sleep deprivation.
    Ahrens AM; Ahmed OJ
    Neurosci Biobehav Rev; 2020 Jan; 108():435-444. PubMed ID: 31756346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subanesthetic ketamine decreases the incentive-motivational value of reward-related cues.
    Fitzpatrick CJ; Morrow JD
    J Psychopharmacol; 2017 Jan; 31(1):67-74. PubMed ID: 27649773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the motivational properties of reward cues: Individual differences.
    Robinson TE; Yager LM; Cogan ES; Saunders BT
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):450-9. PubMed ID: 23748094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual variation in resisting temptation: implications for addiction.
    Saunders BT; Robinson TE
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt A):1955-75. PubMed ID: 23438893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex and strain influence attribution of incentive salience to reward cues in mice.
    Dickson PE; McNaughton KA; Hou L; Anderson LC; Long KH; Chesler EJ
    Behav Brain Res; 2015 Oct; 292():305-15. PubMed ID: 26102561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From sign-tracking to attentional bias: Implications for gambling and substance use disorders.
    Anselme P; Robinson MJF
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109861. PubMed ID: 31931091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental manipulations alter age differences in attribution of incentive salience to reward-paired cues.
    Anderson RI; Bush PC; Spear LP
    Behav Brain Res; 2013 Nov; 257():83-9. PubMed ID: 24050888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment.
    Everett NA; Carey HA; Cornish JL; Baracz SJ
    J Psychopharmacol; 2020 Nov; 34(11):1271-1279. PubMed ID: 33081558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hot 'n' cold of cue-induced drug relapse.
    Pitchers KK; Sarter M; Robinson TE
    Learn Mem; 2018 Sep; 25(9):474-480. PubMed ID: 30115769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sign-tracking to non-drug reward is related to severity of alcohol-use problems in a sample of individuals seeking treatment.
    Watson P; Prior K; Ridley N; Monds L; Manning V; Wiers RW; Le Pelley ME
    Addict Behav; 2024 Jul; 154():108010. PubMed ID: 38479081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual variation in the attribution of incentive salience to social cues.
    Fitzpatrick CJ; Morrow JD
    Sci Rep; 2020 Feb; 10(1):2583. PubMed ID: 32054901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lateral hypothalamus and orexinergic transmission in the paraventricular thalamus promote the attribution of incentive salience to reward-associated cues.
    Haight JL; Campus P; Maria-Rios CE; Johnson AM; Klumpner MS; Kuhn BN; Covelo IR; Morrow JD; Flagel SB
    Psychopharmacology (Berl); 2020 Dec; 237(12):3741-3758. PubMed ID: 32852601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychology and neurobiology of addiction: an incentive-sensitization view.
    Robinson TE; Berridge KC
    Addiction; 2000 Aug; 95 Suppl 2():S91-117. PubMed ID: 11002906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward isolating the role of dopamine in the acquisition of incentive salience attribution.
    Chow JJ; Nickell JR; Darna M; Beckmann JS
    Neuropharmacology; 2016 Oct; 109():320-331. PubMed ID: 27371135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroscience of resilience and vulnerability for addiction medicine: From genes to behavior.
    Morrow JD; Flagel SB
    Prog Brain Res; 2016; 223():3-18. PubMed ID: 26806768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociating the predictive and incentive motivational properties of reward-related cues through the study of individual differences.
    Robinson TE; Flagel SB
    Biol Psychiatry; 2009 May; 65(10):869-73. PubMed ID: 18930184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesions of the ventral hippocampus attenuate the acquisition but not expression of sign-tracking behavior in rats.
    Fitzpatrick CJ; Creeden JF; Perrine SA; Morrow JD
    Hippocampus; 2016 Nov; 26(11):1424-1434. PubMed ID: 27438780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors.
    Fraser KM; Haight JL; Gardner EL; Flagel SB
    Behav Brain Res; 2016 May; 305():87-99. PubMed ID: 26909847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel model of chronic sleep restriction reveals an increase in the perceived incentive reward value of cocaine in high drug-taking rats.
    Puhl MD; Boisvert M; Guan Z; Fang J; Grigson PS
    Pharmacol Biochem Behav; 2013 Aug; 109():8-15. PubMed ID: 23603033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.